Matches in Wikidata for { <http://www.wikidata.org/entity/Q90977277> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- Q90977277 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q90977277 description "scientific article published on 16 August 2018" @default.
- Q90977277 description "wetenschappelijk artikel" @default.
- Q90977277 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90977277 name "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 name "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 type Item @default.
- Q90977277 label "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 label "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 prefLabel "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 prefLabel "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 P1433 Q90977277-4EE540C0-9BAF-4D19-A42A-B06EDAF4F01A @default.
- Q90977277 P1476 Q90977277-46329A40-36B7-4C6C-B3DC-AEEB3D493181 @default.
- Q90977277 P2093 Q90977277-0D510078-EF4C-4A08-B471-BD5372CE8D30 @default.
- Q90977277 P2093 Q90977277-114EFC96-EF6B-4C4C-8D31-DBC515F59D8D @default.
- Q90977277 P2093 Q90977277-1A7258C7-A163-4DC0-82C1-666DE7E03AC8 @default.
- Q90977277 P2093 Q90977277-22AFFAFA-A22C-4B78-A186-C97BCCE7C0DB @default.
- Q90977277 P2093 Q90977277-27A95914-AEB2-409B-817A-7FE0C10B103F @default.
- Q90977277 P2093 Q90977277-2EBB8EF1-5D57-4F05-AE18-0831F32DB862 @default.
- Q90977277 P2093 Q90977277-421B40D1-DD67-4FE5-9AA7-44B3379B8F3A @default.
- Q90977277 P2093 Q90977277-464BEA21-4B80-4BDA-8ED7-6979606A32FE @default.
- Q90977277 P2093 Q90977277-4BFDD0F3-9712-45DE-B6CA-4ED283EB72F4 @default.
- Q90977277 P2093 Q90977277-4D89E667-A8D0-429E-937E-9195CCF842DE @default.
- Q90977277 P2093 Q90977277-5128C88B-D99F-444A-BD0C-F22618470F3B @default.
- Q90977277 P2093 Q90977277-538EFF87-9761-4EB7-A68D-C76273DA26C4 @default.
- Q90977277 P2093 Q90977277-53BA3801-4D8F-42FF-B0B4-BB5A6AF3FCC4 @default.
- Q90977277 P2093 Q90977277-5D298B5E-2280-4134-B98A-4B11A4DE27A2 @default.
- Q90977277 P2093 Q90977277-5E87298D-22FE-492A-BBFD-F8BC9175F379 @default.
- Q90977277 P2093 Q90977277-74DC5A3A-2BBE-449F-8FD6-CB2DC641C4EE @default.
- Q90977277 P2093 Q90977277-7A8AF950-6997-4452-A330-BF4D1FE51624 @default.
- Q90977277 P2093 Q90977277-878F49AF-5C11-4674-A716-3A9470F1FFAB @default.
- Q90977277 P2093 Q90977277-887FC95B-86FD-4420-B264-CB4904889D18 @default.
- Q90977277 P2093 Q90977277-8A0A042C-D112-4615-BB2B-E1CC8718F7B7 @default.
- Q90977277 P2093 Q90977277-9E47B88E-3D31-4925-B3C3-EFC4FD2B8154 @default.
- Q90977277 P2093 Q90977277-A688FF0F-489B-4742-AC82-87E74545418A @default.
- Q90977277 P2093 Q90977277-A86897B5-ACB6-48B0-9E8E-3EB9A2B9FE92 @default.
- Q90977277 P2093 Q90977277-AAA20362-E6B4-4F8E-A267-27AB29A401AA @default.
- Q90977277 P2093 Q90977277-AD34A42F-077D-4450-AA98-324E638B0132 @default.
- Q90977277 P2093 Q90977277-B3682BF2-E2CE-410B-93D5-A6E2453FA3F8 @default.
- Q90977277 P2093 Q90977277-C8D44093-2D6D-4A56-9F86-950E56E8EED0 @default.
- Q90977277 P2093 Q90977277-C9483848-E12A-4226-A111-010ECE55D5BB @default.
- Q90977277 P2093 Q90977277-E9E0422A-EC48-48D8-B705-9E0E312046F1 @default.
- Q90977277 P2093 Q90977277-EAD15310-D1FF-46F7-BD5F-266785A00EB2 @default.
- Q90977277 P2093 Q90977277-EB4C012E-2DBA-4B18-B490-821502301702 @default.
- Q90977277 P2093 Q90977277-F8B54A45-890C-4BA7-899C-DB3B0881E1D4 @default.
- Q90977277 P304 Q90977277-11F5BF7E-5AEA-4467-92DF-9C0DC40CFC74 @default.
- Q90977277 P31 Q90977277-2B6F0676-A18F-4BB9-8450-6E0D63D293B8 @default.
- Q90977277 P356 Q90977277-ABE43404-A403-41C6-91FE-33983B128212 @default.
- Q90977277 P433 Q90977277-2B15D58B-DE44-4905-B6D3-24012181E6D5 @default.
- Q90977277 P478 Q90977277-1900BB3A-F991-418F-823D-9ECBA21785C8 @default.
- Q90977277 P50 Q90977277-3C22BFBB-E39E-4863-8AC8-F04DD5A15CAC @default.
- Q90977277 P577 Q90977277-CE4A4CE8-E64A-4A53-BA28-87D2B1576CDF @default.
- Q90977277 P698 Q90977277-7E25601C-033B-4E98-889F-B412F87DD77B @default.
- Q90977277 P356 ACS.JMEDCHEM.8B00917 @default.
- Q90977277 P698 30113844 @default.
- Q90977277 P1433 Q900316 @default.
- Q90977277 P1476 "Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)" @default.
- Q90977277 P2093 "Andrew Flick" @default.
- Q90977277 P2093 "Ariamala Gopalsamy" @default.
- Q90977277 P2093 "Betsy S Pierce" @default.
- Q90977277 P2093 "Brett D Hollingshead" @default.
- Q90977277 P2093 "Brian S Gerstenberger" @default.
- Q90977277 P2093 "Catherine M Ambler" @default.
- Q90977277 P2093 "David C Limburg" @default.
- Q90977277 P2093 "David Lin" @default.
- Q90977277 P2093 "Eddine Saiah" @default.
- Q90977277 P2093 "Eric Arnold" @default.
- Q90977277 P2093 "Fabien Vincent" @default.
- Q90977277 P2093 "Felix F Vajdos" @default.
- Q90977277 P2093 "Ivan V Efremov" @default.
- Q90977277 P2093 "James D Clark" @default.
- Q90977277 P2093 "Jason Jussif" @default.
- Q90977277 P2093 "Jean-Baptiste Telliez" @default.
- Q90977277 P2093 "Jill Chrencik" @default.
- Q90977277 P2093 "John D Knafels" @default.
- Q90977277 P2093 "John I Trujillo" @default.
- Q90977277 P2093 "Li Xing" @default.
- Q90977277 P2093 "Liying Zhang" @default.
- Q90977277 P2093 "Martin E Dowty" @default.
- Q90977277 P2093 "Martin Hegen" @default.
- Q90977277 P2093 "Mary Ellen Banker" @default.
- Q90977277 P2093 "Matthew F Brown" @default.
- Q90977277 P2093 "Matthew M Hayward" @default.
- Q90977277 P2093 "Peter T Symanowicz" @default.
- Q90977277 P2093 "Raman Sharma" @default.
- Q90977277 P2093 "Tsung H Lin" @default.
- Q90977277 P2093 "Xiaojing Yang" @default.
- Q90977277 P2093 "Xin Yang" @default.
- Q90977277 P2093 "Zhao-Kui Wan" @default.
- Q90977277 P304 "8597-8612" @default.
- Q90977277 P31 Q13442814 @default.
- Q90977277 P356 "10.1021/ACS.JMEDCHEM.8B00917" @default.
- Q90977277 P433 "19" @default.
- Q90977277 P478 "61" @default.
- Q90977277 P50 Q90977274 @default.
- Q90977277 P577 "2018-08-16T00:00:00Z" @default.
- Q90977277 P698 "30113844" @default.